Envisioning how to advance the MASH field
AM Allen, ZM Younossi, AM Diehl… - Nature Reviews …, 2024 - nature.com
Since 1980, the cumulative effort of scientists and health-care stakeholders has advanced
the prerequisites to address metabolic dysfunction-associated steatotic liver disease …
the prerequisites to address metabolic dysfunction-associated steatotic liver disease …
Defining omic-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): in vitro studies
SC Kamble, P Ghosh - Current Opinion in Biomedical Engineering, 2024 - Elsevier
Recent years have seen considerable rise in the cases of non-alcoholic and alcohol-
associated/related liver disease. Though largely, a reversible condition in early stages, if left …
associated/related liver disease. Though largely, a reversible condition in early stages, if left …
High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
PC Valery, S Roche, C Brown, J O'Beirne… - International Journal for …, 2024 - Springer
Background Liver disease is an important contributor to the mortality gap between First
Nations Peoples and non-Indigenous Australian adults. Despite a high burden of metabolic …
Nations Peoples and non-Indigenous Australian adults. Despite a high burden of metabolic …